What's left of the Buffalo Sabres won't include their captain for he remainder of the year.
The NWSL reportedly sent out a memo asking its board of governors to not comment on the Dash investigation.
LONDON — Leaders from Britain's aviation industry joined forces Wednesday to urge the British government to ensure that popular European destinations face the least onerous coronavirus travel restrictions when holidays are allowed again. Under the government's new traffic light system for England, travel to countries in the lowest green category could be opened up to quarantine-free travel from May 17. Arrivals would be required to take a pre-departure test as well as the gold standard PCR test on or before day two of their return to England. They would only need to quarantine if they receive a positive result. The government has said it will categorize destinations — green, amber or red — after analyzing vaccination rates, coronavirus cases and the prevalence of variants of concern. Given the metrics being applied, countries like the United States and Israel are expected to be on the green list immediately, while much of Europe could be placed on the amber list, which would require travellers to self-isolate at home for potentially ten days on their return. Aviation minister Robert Courts said Wednesday that the government should be able to give more details about how countries are characterized in early May so the industry — and potential holidaymakers — can start putting plans in place. “We are giving as much notice as we can,” he said. Lockdown restrictions are being eased across the U.K. after a stringent winter lockdown and the rapid rollout of coronavirus vaccines has seen coronavirus cases — and deaths — fall sharply. However, given that previous waves of the pandemic have arguably been fueled by too-lax border policies, the government has indicated it will take a cautious approach. With much of Europe in the midst of a surge of the pandemic and lockdown restrictions being re-imposed, there are concerns that popular European destinations, such as the beach resorts of the Costa del Sol in Spain or the Greek islands may not make the green list. “We would like to see the green category as expansive as possible,” Chris Garton, chief solutions officer at Heathrow Airport, told lawmakers in the House of Commons. “We understand from a health perspective it’s a proceed with caution time .... but if we err to much on the side of caution then you will have some very devastating effects on the travel sector and the aviation sector,” he added. The aviation industry around the world has been hammered over the past year with passenger numbers down around 95% from pre-pandemic levels. Travel to Europe will play a crucial role in the industry's recovery so any delay in putting popular holiday destinations in the green category would spell further financial difficulties. EasyJet Chief Executive Johan Lundgren said he “would expect almost all major European countries” to be put in the low-risk category immediately and that the airline will be able to fly 20% of its normal schedule between April and June. Lundgren said he's optimistic that many of easyJet's core markets in Europe will make the cut as the rollout of vaccines picks up pace. “I wouldn’t see a reason why you wouldn’t have the majority of the countries of Europe in there," he said. ___ Follow AP’s pandemic coverage at: https://apnews.com/hub/coronavirus-pandemic https://apnews.com/hub/coronavirus-vaccine https://apnews.com/UnderstandingtheOutbreak Pan Pylas, The Associated Press
The "Asia Pacific Bottled Water Market By Product (purified water, mineral water, spring water, sparkling water, distilled water, and other products), By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
The latest news on COVID-19 developments in Canada (all times Eastern): 1:15 p.m. New Brunswick is reporting 16 new cases of COVID-19 today. Health officials say 14 of the new cases are in the hard-hit Edmundston area, which is under lockdown. They say the two other cases are in the Saint John region. The number of active cases is 141, and 19 patients are hospitalized with the disease, including 13 in intensive care. New Brunswick has reported a total of 1,752 confirmed cases of COVID-19 and 33 deaths linked to the virus. --- 11:20 a.m. Health Canada says the Oxford-AstraZeneca vaccine will remain authorized for all adults in Canada after completing a safety review. The department says a new and extremely rare blood clotting syndrome may be linked to the vaccine but the benefits still far outweigh the risks. The conclusions are in line with findings issued in Europe and the United Kingdom last week. The decision comes the day after Canada reported its first-ever case of a blood clot in a patient who received the AstraZeneca vaccine in Quebec. The National Advisory Committee on Immunization is reviewing this information and will decide if it needs to change its recommendation that the vaccine not be used on anyone under the age of 55. --- 11:10 a.m. Quebec is reporting 1,559 new COVID-19 cases today and seven more deaths attributed to the novel coronavirus. Health officials say hospitalizations rose by 17, to 660, and 152 people were in intensive care, a rise of two. The province says it administered 68,192 COVID-19 vaccine doses on Tuesday. Quebec has reported a total of 331,031 infections and 10,763 deaths linked to the virus. --- 11 a.m. Newfoundland and Labrador is reporting three new cases of COVID-19, all of which are linked to travel. Officials say the three people involved are in the eastern region of the province and all are self-isolating. Chief medical officer of health Dr. Janice Fitzgerald says several cases of COVID-19 have been identified in the region of Quebec which borders Labrador. Fitzgerald says testing is available to anyone who visited restaurants in the area between April 5 and April 9 in the Fermont area, but she says the risk to the public is low. --- 10:35 a.m. Ontario is reporting 4,156 cases of COVID-19 and 28 more deaths linked to the virus. Health Minister Christine Elliott says there are 1,254 new cases in Toronto, 593 in Peel Region, and 476 in York Region. She also says there are 340 new cases in Ottawa and 248 in Durham Region. The ministry of health says that 642 people are in intensive care. Ontario says that more than 112,000 doses of a COVID-19 vaccine were administered since Tuesday's report. --- 9 a.m. Two health networks in Toronto say shortages of COVID-19 vaccine are forcing them to limit or close immunization clinics. Scarborough Health Network says it will be closing its Centennial College and Centenary hospital clinics today. University Health Network says it has had to pause registration for appointments for adults over 18 who qualify for vaccination based on their postal code. Both organizations say they will reopen their clinics as soon as they receive more vaccines. --- This report by The Canadian Press was first published April 14, 2021. The Canadian Press
JOHANNESBURG — South Africa's decision to suspend the use of the Johnson & Johnson vaccine due to preliminary reports of rare blood clots has left the country without any shots as it struggles to combat an aggressive coronavirus variant. South Africa has more than 1.5 million confirmed cases of COVID-19, including at least 53,000 deaths, representing more than 30% of all the confirmed cases in Africa's 54 countries. So far, it has only inoculated 290,00 health care workers, all with the J&J vaccine. South Africa's plans to begin large-scale vaccinations next month are dependent upon deliveries of millions of doses of the Johnson & Johnson and the Pfizer-BioNTech vaccines. The government said it expects to vaccinate 40 million of the nation's 60 million people by February 2022. The health minister said South Africa has not had any reports of blood clots in vaccine recipients, the issue that led the U.S. Food and Drug Administration on Tuesday to recommend a pause in the use of the J&J vaccine. Some health experts criticized South Africa's move to follow the U.S. at such a critical juncture. “I had expected the government in South Africa not to be perturbed by the findings from the U.S. I expected that there would not be any disruption," Mosa Moshabela, professor of public health at the University of KwaZulu-Natal, told The Associated Press. "Johnson & Johnson is our only (vaccine) option currently. I really did not expect that we would need to pause.” He said it's likely that South African health officials will be able to resume use of the J&J vaccines soon, although the disruption could contribute to vaccine hesitancy. The National Health and Allied Workers, however, welcomed the pause to ensure the J&J's product is safe, union spokesman Khaya Xaba said. This is not the first abrupt change South Africa has made in its vaccination strategy. In February, the country scrapped its plans to give the AstraZeneca vaccine to its health care workers because a small, preliminary test showed that it gave minimal protection against mild to moderate cases of COVID-19 caused by the variant dominant in South Africa. It was then that South Africa quickly pivoted to the use of the J&J vaccine. The country had already participated in an international clinical trial of the vaccine without any problems. The vaccine also has been found to have good efficacy against the variant dominant in South Africa. The country has ordered 30 million doses of the Johnson & Johnson vaccine. South Africa has also ordered a total of 30 million doses of the Pfizer vaccine. The J&J vaccine is being given to South Africa’s 1.2 million health care workers as a large-scale research study, because the vaccine has not yet been approved for general use in South Africa. Rashika Alberlito, an intensive care unit administrator at a private hospital in Kwazulu-Natal province, was injected last month with the J&J vaccine. She is now extremely worried: she was hospitalized for nearly two weeks in 2015 because of a blood clot in one of her lungs. Alberlito remains on blood-thinning medication, and the news about the possible link between the J&J vaccine and blood clots concerned her. “I asked about the safety of the vaccine given my condition, and I was assured it was safe," Alberlito told The Associated Press. “That is why I was very shocked and worried to hear the announcement by the minister, but I hope the test results would confirm no causal link between the blood clots and the vaccine.” Like Alberlito, many South Africans are hoping the Johnson & Johnson vaccine will be deemed safe. While acknowledging the importance of vaccine safety, professor Moshabela said it is urgent that South Africa vaccinate millions of people as soon as possible. He hopes the suspension of the J&J vaccine will not last long. “In the meantime, you’re going to have a lot of people who catch COVID, and some of them will die while you delay the (vaccine) rollout," Moshabela said. Potential problems with the J&J vaccine could affect all of Africa, as the African Union recently secured orders for 220 million doses of the vaccine to be used across the continent. “The last thing that we want to have is any cloud of doubt around any vaccines in Africa and the world. It just strengthens that belief that vaccines are not safe on the continent of Africa, or in the world for that matter,” Dr. John Nkengasong, director of the Africa Centers for Disease Control and Prevention, said in a webinar Wednesday. ___ Follow all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak Mogomotsi Magome And Andrew Meldrum, The Associated Press
The "2021 Global Forecast for Valves, Intake and Exhaust, All Other Engine Types (2022-2027 Outlook) - Manufacturing & Markets Report" has been added to ResearchAndMarkets.com's offering.
The Federal Reserve will reduce its monthly bond purchases before it commits to an interest rate increase, Fed Chair Jerome Powell said on Wednesday, clarifying the order of monetary policy changes that are still months if not years in the future. The Fed is currently buying $120 billion a month in government-issued and government-backed securities, and has pledged to continue doing that until the economy is more fully recovered. That program will start to phase out before the Fed gets to the point of raising the target interest rate from its near zero level, the second major way in which the central bank currently supports the economy.
General Motors Co and South Korean joint-venture partner LG Chem Ltd will announce a second U.S. battery cell manufacturing plant on Friday, revealing plans for a $2.3 billion factory in Spring Hill, Tennessee, three people familiar with the matter said. The plant will use a different, more cost-effective battery chemistry than the one the companies will offer from the joint-venture plant they are building in Lordstown, Ohio, the sources said on Wednesday. The battery will be for the Cadillac Lyriq electric crossover vehicle that GM will begin building at its nearby Spring Hill assembly plant next year, the sources said.
(Bloomberg) -- The Federal Reserve will likely taper off its bond purchases before considering raising interest rates, Chairman Jerome Powell said.“We will reach the time at which we will taper asset purchases when we’ve made substantial further progress toward our goals from last December, when we announced that guidance,” Powell said Wednesday in a virtual event hosted by the Economic Club of Washington. “That would in all likelihood be before -- well before -- the time we consider raising interest rates. We haven’t voted on that order but that is the sense of the guidance.”Policy makers will wait until inflation has reached 2% sustainably and the labor-market recovery is complete before considering lifting interest rates, and the combination is unlikely to happen before 2022, he said. Their forecasts last month signaled rates being held near zero through 2023.“When the purchases go to zero, the size of the balance sheet is constant, and when bonds mature you reinvest them,” Powell said. “And then another step -- and we took this late in the day in the last cycle -- was to allow bonds to start to runoff. And we haven’t decided whether to do that or not.”Powell added that he doesn’t think the Fed would actually sell bonds into the market, something it also didn’t do during the recovery from the 2008 financial crisis.Patience PledgedPowell and his colleagues have pledged to be patient and maintain aggressive monetary policy support, even as the economic recovery from the pandemic picks up speed. That dovish view has helped U.S. stocks reach fresh record highs. Recent data has also painted a brighter picture as vaccinations spread and the economy reopens, with employers adding 916,000 jobs in March.“Most members of the committee did not see raising interest rates until 2024, but that isn’t a committee forecast, it isn’t something we vote on or or act on as a group -- it really is just our assessment,” Powell said. “Markets focus too much on what we call the economic predictions, and I would focus more on on the outcomes that we’ve described.”Fed policy makers substantially lifted their growth and employment forecasts at the central bank’s meeting last month. Their median estimate sees the economy expanding 6.5% this year and the unemployment rate declining to 4.5% by the end of 2021.Powell said the U.S. is going into a period of faster growth and job creation, and that the main risk is another spike in Covid-19 cases due to virus strains that may be more difficult to treat.The Fed chair said it would be wise to keep wearing masks and stay socially distanced “at least for a while longer.”Minutes of the central bank’s March meeting released April 7 said policy makers expect it will likely be “some time until substantial further progress” was made on employment and inflation. That refers to the tests they’ve set for scaling back bond purchases of $120 billion a month.(Updates with comment on sequence from first paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Belgium delayed beyond Friday the start of administering Johnson & Johnson COVID-19 vaccines at the company's request, the government said in a statement on Wednesday. The European Medicines Agency (EMA) expects to issue a recommendation on J&J next week after the U.S. drugmaker delayed its COVID-19 shot and Denmark was dropping a similar vaccine from AstraZeneca Plc over the risk of blood clotting. Belgium said it received the first 36,000 J&J shots earlier this week and was expecting 62,400 more this month, with deliveries for May and June still to be decided.
Food and beverage manufacturers are one step closer to launching sugar reduced products. Reb M Sugar Reduction solution in Europe. Rancho Santa Margarita, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- Navigating sugar reduction solutions in Europe just got better for food and beverage brands. Today, SweeGen announced its next generation Bestevia Rebaudioside M (Reb M) stevia sweetener is in the final phase before the European Union publishes the approval in a few months. In anticipation of the published approval, SweeGen is fast tracking the commercial scale up of the non-GMO Bestevia Reb M at its manufacturing facility in Europe. The regulatory step is the last hurdle to satisfying the demand for the highly sought-after stevia sweetener in the EU. For the past few years, the company has been collaborating with major food and beverage manufacturers in Europe to explore application developments for creating sweet taste innovations. Now, the products are near ready to launch on the market. In conjuction with the anticipated Reb M approval, Sweegen launched its new Food and Beverage Applications Center in London in January 2021. The Center will be home to sugar reduction product development for brands in Europe. It will also serve as a creative center to explore and discover product innovations motivated by consumer trends and regional tastes. “Reaching this last stage in the EU regulatory approval process for our Bestevia Reb M is a key milestone in our journey to inspire new product launches, and provide confidence for brands that are in their final phases for creating great tasting, reduced sugar and healthier products,” said Michael Halvorsen, senior director of business development, EMEA. “Our new creative center in London allows us to help our customers reach their sugar reduction goals with new product innovations, and our European manufacturing facility in Europe enables the rapid commercialization of 3,000 metric tons of high-purity stevia per year.” Bestevia Reb M is great news for both consumers and brands. As consumers take action on reducing their sugar intake while demanding great taste, food and beverage manufacturers will have better sugar reduction solutions to meet their product challenges. “Regional access to sustainable Bestevia Reb M is very important as it provides a low cost-in-use sugar reduction solution to product developers, and with SweeGen as a supplier and applications collaborator, together, we can create consumer-winning products,” said Halvorsen. Non-GMO stevia sweeteners have led the way in replacing sugar in foods and beverages, nutritional products, and many other market products world-wide. Innova market research reported that in France, from Jan. 2019 to Aug. 2020, sports nutrition product launches using stevia increased by 43%. SweeGen offers brands cost-effective and rapid innovation for sugar reduction solutions for beverage, dairy, savory and bakery with its Bestevia Taste Solutions for Europe. SweeGen is the first company to receive the Eueopean Food Safety Authority (EFSA) panel’s safety status for any steviol glycoside produced by alternative and sustainable technologies. To achieve high purity clean-tasting stevia leaf sweeteners, SweeGen uses a bioconversion process starting with stevia leaf. This process enabled SweeGen to obtain the Non-GMO Project verification for its Bestevia stevia sweeteners in the US market. “We are happy to move into this final approval step with the EU Commission because it provides our customers with confidence they need to proceed with their new product development and launches for sugar reduced innovation in Europe,” said Hadi Omrani, director of regulatory affairs. Bestevia Reb M was commercialized in 2017 and has already been approved in many regions around the world. ### About SweeGen SweeGen provides sweet taste solutions for food and beverage manufacturers around the world. We are on a mission to reduce the sugar and artificial sweeteners in our global diet. Partnering with customers, we create delicious zero-sugar products that consumers love. With the best next generation stevia sweeteners in our portfolio such as Bestevia® Rebs B, D, E, I, M, and N, along with our deep knowledge of flavor modulators and texturants, SweeGen delivers market-leading solutions that customers want and consumers prefer. For more information please contact email@example.com and visit SweeGen’s website, www.sweegen.com. Cautionary Statement Concerning Forward-Looking Statements This press release contains forward-looking statements, including, among other statements, statements regarding the future prospects for Reb M stevia leaf sweetener. These statements are based on current expectations, but are subject to certain risks and uncertainties, many of which are difficult to predict and are beyond the control of SweeGen, Inc. Relevant risks and uncertainties include those referenced in the historic filings of SweeGen, Inc. with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. SweeGen, Inc. assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Attachment Reb M sugar reduction solution in Europe CONTACT: Ana Arakelian SweeGen, Inc. 949-635-1991 firstname.lastname@example.org
The "North America Tonic Water Market By Flavor (Plain and Flavored), By Distribution Channel (Off-trade, On-trade and Online Retail), By Packaging Form (Cans and Bottles), By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
In a statement, the Syrian Foreign Ministry said it condemned in the strongest terms the report issued Monday by the Netherlands-based Organization for the Prohibition of Chemical Weapons. It was the second time the OPCW’s Investigation and Identification Team has concluded that Syrian government armed forces likely were responsible for a gas attack.
American Paradigm Schools Announces Phased Reopening of Four Philadelphia Charter Schools
MONTREAL — A teacher in Sherbrooke, Que., who was picketing with her colleagues this morning was struck by a car in what police are calling a deliberate gesture. Sherbrooke police spokesman Martin Carrier says the woman was participating in a teachers strike outside her high school around 9:30 a.m. when she was struck by a driver who allegedly drove into the picket line. Carrier says the woman escaped with minor injuries. The 54-year-old suspect left the scene but was later arrested at his home for assault with a weapon. Carrier says witnesses indicated the suspect has a connection to the school and was possibly the father of a student, but says that has yet to be confirmed. The victim was one of tens of thousands of Quebec teachers who held an early-morning strike today that began just after midnight and lasted until 9:30 a.m. The teachers have been without a contract since March 2020. In Montreal this morning, teachers could be seen grouped outside schools waving signs and demanding better working conditions. The union representing the teachers, called Centrale des syndicats du Quebec, says the timing of the strike was designed to put pressure on management without affecting students' learning. Quebec Superior Court on Monday refused a request by the school boards to deny teachers the right to hold the strike, paving the way for the job action to proceed. The province's workplace tribunal was supposed to hear the case Tuesday afternoon, but the head of one of the teachers unions said that hearing turned out to be unnecessary after discussions were held between the two parties. Union head Josee Scalabrini told The Canadian Press that the employer wanted reassurance on some aspects of the strike, including that the teachers would be in class by 9:31 a.m. Several school boards announced classes would move online for the day because the strike affected school buses and early-morning supervision. This report by The Canadian Press was first published April 14, 2021. The Canadian Press
A survey from last year found trust in government had fallen in England but remained steady in Scotland.
TORONTO — Organizers of the Juno Awards say they're postponing this year's 50th anniversary show in Toronto until June 6 as COVID-19 cases rage. It's the second time the country's biggest night in music has been pushed this year as the Canadian Academy of Recording Arts and Sciences contends with ever-changing Ontario rules meant to slow the spread of the virus. Already the annual celebration had been moved to May 16 from an originally planned date in mid-March under hopes that warmer weather might allow some performances to be held outdoors with safety efforts in place. However, the province has seen a spike in COVID-19 cases more recently, with a larger proportion coming from more contagious variants that led to more hospitalizations and pushed the province to issue stay-at-home orders. The latest Junos delay was made "out of an abundance of caution in response to the evolving COVID-19 pandemic," CARAS said Wednesday in a statement. Juno Awards head Allan Reid declined an interview request. Complicating matters is the award show's role in supporting Canada's music industry, which is caught in the middle of Ontario COVID-19 guidelines that favour film and TV productions over streaming concerts. Earlier this month, several Ontario concert venue owners called on Premier Doug Ford's government to offer more transparency around why his "emergency brake" plan outlawed live streaming concerts at local venues while film and TV shoots could continue to move ahead with COVID-19 protocols. As a nationally televised broadcast put on by Insight Productions, the Juno Awards would likely qualify under Ford's current COVID-19 production rules. But on the other hand, the show would be packed with live performances from the very industry that's being prevented from streaming in small concert venues. The Junos organizers had hoped to stage some of the music moments inside prominent local venues, including Toronto's Horseshoe Tavern, a move that blurred the lines between TV production and live streaming rules even further. This year's Junos was originally set to be a splashy event with some of the country's biggest stars in attendance, but organizers have been forced to rein in expectations over the past year as the reality of COVID-19 made some of their ideas impossible. The Weeknd leads the 2021 Junos with six nominations while Toronto pop singer/songwriter JP Saxe, Justin Bieber and Jessie Reyez all have five nods. Details on performers, presenters and Juno Week virtual events will be revealed in the coming weeks, CARAs said. This report by The Canadian Press was first published April 14, 2021. David Friend, The Canadian Press
FRISCO, Texas — High-scoring Dallas Stars forward Alexander Radulov will not return this season because he needs surgery to repair a core muscle injury. Goaltender Ben Bishop won't play at all. Stars general manager Jim Nill said Wednesday that Radulov is expected to be fully recovered for the 2021-22 season. Radulov was limited to only 11 games this season because of a lower-body injury. Bishop, who hasn't played any games after twice having knee surgery last year, will not play this season. Nill said the move will allow Bishop time to continue his rehabilitation and return to full health for the start of 2021-22. Radulov hasn't played since March 18, and Nill had said earlier this week that the forward would see a specialist before a long-term decision was made on his playing status. The Stars didn't say when the surgery would be done. In his 11 games, Radulov had 12 points (four goals, eight assists) and a plus-9 rating. Radulov has one season left on his five-year deal, while Bishop has two seasons left on a six-year deal he signed with the Stars. ___ More AP NHL: https://apnews.com/hub/NHL and https://twitter.com/AP_Sports The Associated Press
Radnor, Pennsylvania--(Newsfile Corp. - April 14, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Leidos Holdings, Inc. (NYSE: LDOS) ("Leidos") investors that a securities class action lawsuit has been filed on behalf of those who purchased or acquired Leidos securities between May 4, 2020 and February 23, 2021, inclusive (the "Class Period").Lead Plaintiff Deadline: May 5, 2021Website: https://www.ktmc.com/leidos-holdings-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=leidos Contact: James Maro, Esq. (484) 270-1453Adrienne Bell, ...